Shenzhen - Delayed Quote CNY

Canature Health Technology Co., Ltd. (300272.SZ)

5.24 +0.05 (+0.96%)
At close: 3:04 PM GMT+8
Loading Chart for 300272.SZ
DELL
  • Previous Close 5.19
  • Open 5.03
  • Bid 5.23 x --
  • Ask 5.24 x --
  • Day's Range 5.14 - 5.41
  • 52 Week Range 3.56 - 6.81
  • Volume 25,009,534
  • Avg. Volume 16,655,182
  • Market Cap (intraday) 3.024B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 22.78
  • EPS (TTM) 0.23
  • Earnings Date --
  • Forward Dividend & Yield 0.16 (2.94%)
  • Ex-Dividend Date Jan 24, 2024
  • 1y Target Est --

Canature Health Technology Co., Ltd. engages in the research, development, manufacture, production of residential water treatment products in China, the Middle East, Europe, rest of Asia, North America, and internationally. Its products include whole-house water purifiers and softeners, commercial purified water dispensers, membrane reverse osmosis water purifiers, multi-way control valves, composite material pressure vessels, and membrane elements. The company was formerly known as Shanghai Canature Environmental Products Co., Ltd. and changed its name to Canature Health Technology Co., Ltd. in July 2018. Canature Health Technology Co., Ltd. was founded in 2001 and is headquartered in Shanghai, China.

www.canature.com

1,532

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 300272.SZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300272.SZ
14.61%
SSE Composite Index
3.82%

1-Year Return

300272.SZ
3.38%
SSE Composite Index
5.40%

3-Year Return

300272.SZ
7.30%
SSE Composite Index
11.10%

5-Year Return

300272.SZ
13.29%
SSE Composite Index
1.13%

Compare To: 300272.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300272.SZ

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    3.00B

  • Enterprise Value

    3.13B

  • Trailing P/E

    21.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.80

  • Price/Book (mrq)

    2.37

  • Enterprise Value/Revenue

    1.86

  • Enterprise Value/EBITDA

    15.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.98%

  • Return on Assets (ttm)

    3.70%

  • Return on Equity (ttm)

    11.47%

  • Revenue (ttm)

    1.66B

  • Net Income Avi to Common (ttm)

    132.43M

  • Diluted EPS (ttm)

    0.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    974.16M

  • Total Debt/Equity (mrq)

    76.98%

  • Levered Free Cash Flow (ttm)

    54.21M

Company Insights: 300272.SZ

People Also Watch